Native State Kinetic Stabilization as a Strategy To Ameliorate Protein Misfolding Diseases: A Focus on the Transthyretin Amyloidoses
Citations Over TimeTop 10% of 2005 papers
Abstract
Small molecule-mediated protein stabilization inside or outside of the cell is a promising strategy to treat protein misfolding/misassembly diseases. Herein we focus on the transthyretin (TTR) amyloidoses and demonstrate that preferential ligand binding to and stabilization of the native state over the dissociative transition state raises the kinetic barrier of dissociation (rate-limiting for amyloidogenesis), slowing and in many cases preventing TTR amyloid fibril formation. Since T119M-TTR subunit incorporation into tetramers otherwise composed of disease-associated subunits also imparts kinetic stability on the tetramer and ameliorates amyloidosis in humans, it is likely that small molecule-mediated native state kinetic stabilization will also alleviate TTR amyloidoses.
Related Papers
- → Glavonoid, a possible supplement for prevention of ATTR amyloidosis(2021)9 cited
- → Role of the Glutamic Acid 54 Residue in Transthyretin Stability and Thyroxine Binding,(2009)20 cited
- → Specific Disruption of Transthyretin(105–115) Fibrilization Using “Stabilizing” Inhibitors of Transthyretin Amyloidogenesis(2012)5 cited
- → Disulfide Bond Formation of Transthyretin (TTR) as Possible Initial Step of Familial Amyloid Polyneuropathy (FAP)(1991)2 cited
- → Unraveling the Possible Mechanism Behind Leptomeningeal Amyloidosis Using as Model a Highly Unstable Transthyretin Tetramer(2010)